VOR BIOPHARMA INC

CUSIP: 929033108 Class: Common Stock

Sarissa Capital Management LP's Holding History (CIK: 0001577524)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025
Shares 508,016 Value ($000) $823 Avg Close — Range —
Q1 2025
Shares 508,016 Value ($000) $365 Avg Close — Range —
Q4 2024
Shares 618,000 Value ($000) $686 Avg Close — Range —
Q3 2024
Shares 618,000 Value ($000) $433 Avg Close — Range —
Q2 2024
Shares 618,000 Value ($000) $618 Avg Close — Range —
Q1 2024
Shares 618,000 Value ($000) $1,465 Avg Close — Range —
Q4 2023
Shares 618,000 Value ($000) $1,391 Avg Close — Range —
Q3 2023
Shares 618,000 Value ($000) $1,310 Avg Close — Range —
Q2 2023
Shares 618,000 Value ($000) $1,910 Avg Close — Range —
Q1 2023
Shares 618,000 Value ($000) $3,325 Avg Close — Range —
Q4 2022
Shares 618,000 Value ($000) $4,110 Avg Close — Range —
Q3 2022
Shares 618,000 Value ($000) $2,460 Avg Close — Range —
Q2 2022
Shares 618,000 Value ($000) $3,071 Avg Close — Range —
Q1 2022
Shares 707,010 Value ($000) $4,270 Avg Close — Range —
Q4 2021
Shares 707,010 Value ($000) $8,215 Avg Close — Range —
Q3 2021
Shares 707,010 Value ($000) $11,086 Avg Close — Range —
Q2 2021
Shares 707,010 Value ($000) $13,186 Avg Close — Range —
Q1 2021
Shares 707,010 Value ($000) $30,472 Avg Close — Range —